AJP - Endo Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab (March 30, 2004). doi:10.1152/ajpendo.00040.2004
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
287/2/E269    most recent
00040.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Camacho, R. C.
Right arrow Articles by Wasserman, D. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Camacho, R. C.
Right arrow Articles by Wasserman, D. H.
Submitted on January 28, 2004
Accepted on March 25, 2004

Hepatic Glucose Autoregulation: Responses to Small Non-Insulin-Induced Changes in Arterial Glucose

Raul C. Camacho1*, D. Brooks Lacy1, Freyja D. James1, Robert H. Coker1, and David H. Wasserman1

1 Department of Molecular Physiology and Biophysics and Diabetes Research and Training Center, Vanderbilt University School of Medicine, Nashville, TN, USA

* To whom correspondence should be addressed. E-mail: Raul.Camacho{at}vanderbilt.edu.

Autoregulation of glucose production (Ra) is an important defense against overt hypoglycemia during exercise. The purpose of this study was to determine whether the body is able to autoregulate Ra in response to small non-insulin-induced changes (<20 mg.dL-1) in arterial plasma glucose. Dogs had sampling (artery, portal vein, hepatic vein) and infusion (vena cava, portal vein, renal arteries) catheters, and flow probes (hepatic artery, portal vein) implanted >16 days prior to a study. Protocols consisted of equilibration (-130 to -30 min), basal (-30 to 0 min) and bilateral renal arterial phloridzin infusion (0 to 180 min) periods. SRIF was infused and glucagon and insulin were replaced in the portal vein to maintain basal levels of pancreatic hormones. In one protocol (Phl±Glc), glucose was allowed to fall from t=0 to 90 min. This was followed by a period where glucose was infused to restore euglycemia (90 to 150 min), and a period where glucose was allowed to fall again (150 to 180 min). In a second protocol (EC), glucose was infused to compensate for the renal loss of glucose due to phloridzin, and maintain euglycemia using a clamp technique from t=0 to 180 min. Arterial insulin, glucagon, cortisol, and catecholamines were similar between groups and did not change during the study. In Phl±Glc, glucose fell by ~20 mg.dL-1 by t=90 min, with phloridzin infusion. Glucose was returned to basal levels with exogenous glucose infusion by t=105 min, and then fell again after t=150 min by ~20 mg.dL-1. Glucose was clamped at basal levels throughout the study in EC. Ra did not change from basal with phloridzin infusion in Phl±Glc despite the fall in glucose for the first 90 min. Ra was significantly suppressed with a restoration of euglycemia from t=90 to 150 min (p<0.05), and returned to basal when glucose was allowed to fall again from t=150 to 180 min. Ra did not change from basal in EC with phloridzin and glucose infusion. In conclusion, as with exercise, the liver autoregulates Ra in response to small changes in glucose independent of changes in pancreatic hormones at rest. However, in the resting dog the liver is more sensitive to a small increment, rather than decrement, in arterial glucose.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2004 by the American Physiological Society.